Abstract:In this study library of bisubstarte analogues, uridine‐mimetic peptide conjugates are designed, synthesised and evaluated for their O‐linked β‐N‐acetylglucosamine transferase (OGT) inhibition activity. In this approach uridine diphosphate moiety from sugar donor UDP‐GlcNAc is replaced with quinolinone‐6‐sulfonamide (Q6S) or quinolone‐4‐carboxamide (Q4 C). OGT inhibition assay suggested that bisubstarte analogues have retained OGT inhibition and enzyme inhibition is peptide sequence dependent. Our finding demonstrates that replacement of charged nucleotide with quinolinone heterocycles will aid development of cell‐permeable OGT inhibitors in the future. O‐linked β‐N‐acetylglucosamine transferase (OGT) is the pivotal mammalian enzyme that serves as a nutrient sensor, linking metabolic status to diverse cellular signalling pathways by catalyzing N‐acetylglucosamine transfer to various proteins and detects fluctuations in UDP‐GlcNAc concentrations. Increased UDP‐GlcNAc levels induce O‐GlcNAcylation of proteins, influencing the stability and localization of biomolecules, including transcription factors, kinases, phosphatases, tumour suppressors, and histone‐modifying proteins. Dysregulation and excessive OGT expression can adversely impact cellular processes. The lack of potent and selective inhibitors for OGT has impeded the progress in understanding the enzyme and its molecular mechanisms. This research article details the successful development and synthesis of a series of bisubstrate analogue inhibitors, specifically focusing on inhibiting the O‐GlcNAc transferase (OGT) enzyme. Compound 29 emerged as a promising inhibitor, demonstrating an IC50 value of 134.40 μM in in‐vitro assays. The study emphasizes the crucial role of the acceptor substrate analogue in bisubstrate inhibitor design, highlighting its equal importance alongside the donor substrate analogue. While donor substrate mimetics alone exhibited limited inhibition, their conjugation with appropriate peptides significantly enhanced the overall potency of the final bisubstrate inhibitor. Particularly, peptide derivatives proved superior as acceptor substrate analogues compared to normal substrate peptides. Preliminary data suggest the potential of uridine‐mimetics, like Q6S and Q4 C, following scaffold structure refinement. In‐silico predictions propose that replacing pyrophosphate with a flexible linker substantially improves physicochemical properties relevant to cell permeation. This comprehensive investigation offers valuable insights into designing and optimizing bisubstrate analogue inhibitors for OGT, revealing potential avenues for further refinement and development.

Substrate Specificity Provides Insights into the Sugar Donor Recognition Mechanism of O-GlcNAc Transferase (OGT)

Extreme Substrate Promiscuity of the Neisseria Oligosaccharyl Transferase Involved in Protein O-Glycosylation

Elucidating the protein substrate recognition of O-GlcNAc transferase (OGT) toward O-GlcNAcase (OGA) using a GlcNAc electrophilic probe

Revealing the conformational dynamics of UDP-GlcNAc recognition by O-GlcNAc transferase via Markov state model

O-GlcNAcylation of Thr12/Ser56 in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity

Spatiotemporal Activation of Protein O-GlcNAcylation in Living Cells.

Production of Glycopeptide Derivatives for Exploring Substrate Specificity of Human OGA Toward Sugar Moiety

The sugar donor specificity of plant family 1 glycosyltransferases

Exploration of O-GlcNAc transferase glycosylation sites reveals a target sequence compositional bias

Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily

Substrate Promiscuity, Crystal Structure, and Application of a Plant UDP-Glycosyltransferase UGT74AN3

A peptide panel investigation reveals the acceptor specificity of O-GlcNAc transferase.

Recognition of a glycosylation substrate by the O-GlcNAc transferase TPR repeats

O-Glycosylation of EGF Repeats: Identification and Initial Characterization of a UDP-glucose: Protein O-glucosyltransferase

Regulatory Role of One Critical Catalytic Loop of Polypeptide N-Acetyl-Galactosaminyltransferase-2 in Substrate Binding and Catalysis During Mucin-Type O-Glycosylation

Mucin-type O-glycosylation is controlled by short- and long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family

Single Quantum Dot-Based Nanosensor for Sensitive Detection of O-GlcNAc Transferase Activity

Structural insights into the catalytic selectivity of glycosyltransferase SgUGT94-289-3 towards mogrosides

Bisubstrate Uridine‐Mimetic‐Peptide Conjugates as O‐GlcNAc Transferase (OGT) Inhibitors

Photoactivatable O‐GlcNAc transferase library enables covalent chemical capture of solvent‐exposed TPR domain interactions

C-Terminal Tag Location Hampers in Vitro Profiling of OGT Peptide Substrates by Mrna Display